Cuizhen Xiao

Title: Cuizhen Xiao: Innovator in Bioengineering and Biotechnology

Introduction

Cuizhen Xiao is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of bioengineering and biotechnology, particularly in the development of recombinant antibodies. His innovative work has led to advancements that enhance the efficacy and stability of therapeutic antibodies.

Latest Patents

Cuizhen Xiao holds a patent for a "Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof." This invention focuses on a method for preparing a recombinant antibody with a unique glycan profile, produced by genome-edited CHO host cells. The method utilizes TALEN technology to edit the FUT8 gene in CHO cells adapted for serum-free suspension growth. The resulting antibodies exhibit a unique glycan profile characterized by non-fucosylated N-linked oligosaccharide chains, low N-glycosylation heterogeneity, and uniform carbohydrate chains. These antibodies demonstrate significantly increased antibody-dependent cellular cytotoxicity (ADCC) and greater stability.

Career Highlights

Cuizhen Xiao is associated with Bio-Thera Solutions, Ltd., where he continues to push the boundaries of biotechnology. His work has been instrumental in developing innovative solutions that address critical challenges in the field of therapeutic antibodies.

Collaborations

Cuizhen Xiao collaborates with notable colleagues, including Chao Qin and Yuanqing Zhou. Their combined expertise fosters a dynamic research environment that drives innovation in biotechnology.

Conclusion

Cuizhen Xiao's contributions to bioengineering and biotechnology exemplify the impact of innovative thinking in the development of therapeutic solutions. His patented work on recombinant antibodies showcases the potential for enhanced treatments in the medical field.